XETR
MED
Market cap162mUSD
Jun 12, Last price
2.96EUR
1D
0.00%
1Q
2.07%
Jan 2017
-49.57%
IPO
-73.24%
Name
Mediclin AG
Chart & Performance
Profile
MEDICLIN Aktiengesellschaft operates hospitals in Germany. The company operates through Post-Acute, Acute, and Other Activities segments. It offers medical services in the areas of neurology, psychosomatics, orthopaedics, internal medicine, cardiology, oncology, geriatrics, psychiatry, surgery, nursing care, and others. The company also provides services in the areas of ENT and acute outpatient services. As of December 31, 2021, it owned 34 clinics, 7 nursing care facilities, and 11 medical care centres with a total capacity of 7,831 beds and 482 nursing places in 11 German federal states. The company is headquartered in Offenburg, Germany.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 761,599 8.07% | 704,700 4.69% | |||||||
Cost of revenue | 635,482 | 145,300 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 126,117 | 559,400 | |||||||
NOPBT Margin | 16.56% | 79.38% | |||||||
Operating Taxes | 2,035 | 58 | |||||||
Tax Rate | 1.61% | 0.01% | |||||||
NOPAT | 124,082 | 559,342 | |||||||
Net income | (10,776) -214.15% | 9,441 545.98% | |||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
Debt | |||||||||
Debt current | 50,962 | 50,181 | |||||||
Long-term debt | 815,305 | 860,848 | |||||||
Deferred revenue | |||||||||
Other long-term liabilities | 84,371 | 83,456 | |||||||
Net debt | 750,915 | 779,568 | |||||||
Cash flow | |||||||||
Cash from operating activities | 78,001 | 34,639 | |||||||
CAPEX | (37,576) | (26,019) | |||||||
Cash from investing activities | (9,511) | (6,243) | |||||||
Cash from financing activities | (45,479) | (56,172) | |||||||
FCF | 139,144 | 485,142 | |||||||
Balance | |||||||||
Cash | 115,286 | 88,039 | |||||||
Long term investments | 67 | 43,422 | |||||||
Excess cash | 77,273 | 96,227 | |||||||
Stockholders' equity | 66,638 | 117,837 | |||||||
Invested Capital | 693,587 | 694,201 | |||||||
ROIC | 17.88% | 81.75% | |||||||
ROCE | 16.59% | 70.77% | |||||||
EV | |||||||||
Common stock shares outstanding | 47,500 | 47,500 | |||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | 212,122 | 630,804 | |||||||
EV/EBITDA | |||||||||
Interest | 23,948 | 10,623 | |||||||
Interest/NOPBT | 18.99% | 1.90% |